Co-Founder And Chief Executive Officer
CurrentEditpep is a genome editing therapeutics company that leverages a novel platform technology for safely delivering CRISPR enzymes into human cells and tissues. Editpep’s core technologies were invented by co-founders at UC Berkeley and are now being developed to pursue therapies for diseases of the central nervous system.